A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and Histology

PURPOSE: While the Trastuzumab for Gastric Cancer (ToGA) trial demonstrated the efficacy and safety of trastuzumab-based chemotherapy in HER2-positive metastatic gastric cancer, the overall survival (OS) benefit was not found in Asian and diffuse-type cancer patients. The aim of the study is to inve...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Res Treat
Autori principali: Yi, Jun Ho, Kang, Jung Hun, Hwang, In Gyu, Ahn, Hee Kyung, Baek, Hyun Jin, Lee, Soon Il, Lim, Do Hyoung, Won, Young-Woong, Ji, Jun Ho, Kim, Hyo Song, Rha, Sun Young, Oh, Sung Yong, Lee, Kyung Eun, Lim, Taekyu, Maeng, Chi Hoon, Kim, Moon Jin, Kim, Seung Tae, Lee, Jeeyun, Park, Joon Oh, Park, Young Suk, Lim, Ho Yeong, Kang, Won Ki, Park, Se Hoon
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean Cancer Association 2016
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4843742/
https://ncbi.nlm.nih.gov/pubmed/26323641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2015.155
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi